Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122797552 | 12279755 | 2 | F | 20160403 | 20160901 | 20160418 | 20160906 | EXP | IT-PFIZER INC-2016207480 | PFIZER | 64.00 | YR | F | Y | 0.00000 | 20160906 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122797552 | 12279755 | 1 | PS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 287.3 MG, CYCLIC | W113775AA | 20571 | 287.3 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||
| 122797552 | 12279755 | 2 | SS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | IR21406AZ | 20571 | CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||||
| 122797552 | 12279755 | 3 | SS | ZALTRAP | ZIV-AFLIBERCEPT | 1 | Intravenous (not otherwise specified) | 264 MG, CYCLIC | 4F003B | 0 | 264 | MG | SOLUTION FOR INFUSION | ||||||
| 122797552 | 12279755 | 4 | SS | LEUCOVORIN /00566701/ | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 638.5 MG, CYCLIC | 0 | 638.5 | MG | ||||||||
| 122797552 | 12279755 | 5 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous bolus | 638.5 MG, CYCLIC | PP01651 | 0 | 638.5 | MG | SOLUTION FOR INFUSION | ||||||
| 122797552 | 12279755 | 6 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous drip | 3831 MG, CYCLIC | PP01537 | 0 | 3831 | MG | SOLUTION FOR INFUSION | ||||||
| 122797552 | 12279755 | 7 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 8 MG, UNK | 0 | 8 | MG | SOLUTION FOR INJECTION | |||||||
| 122797552 | 12279755 | 8 | C | ATROPINE. | ATROPINE | 1 | Intravenous (not otherwise specified) | 0.2 MG, UNK | 0 | .2 | MG | SOLUTION FOR INJECTION | |||||||
| 122797552 | 12279755 | 9 | C | PALONOSETRON | PALONOSETRON | 1 | Intravenous (not otherwise specified) | 250 UG, UNK | 0 | 250 | UG | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122797552 | 12279755 | 1 | Colorectal cancer metastatic |
| 122797552 | 12279755 | 3 | Colorectal cancer metastatic |
| 122797552 | 12279755 | 4 | Colorectal cancer metastatic |
| 122797552 | 12279755 | 5 | Colorectal cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122797552 | 12279755 | DE |
| 122797552 | 12279755 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122797552 | 12279755 | Anaemia | |
| 122797552 | 12279755 | Febrile neutropenia | |
| 122797552 | 12279755 | Platelet count decreased | |
| 122797552 | 12279755 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122797552 | 12279755 | 1 | 20160323 | 20160323 | 0 | |
| 122797552 | 12279755 | 3 | 20160323 | 20160323 | 0 | |
| 122797552 | 12279755 | 4 | 20160323 | 20160323 | 0 | |
| 122797552 | 12279755 | 5 | 20160323 | 20160323 | 0 | |
| 122797552 | 12279755 | 6 | 20160323 | 20160325 | 0 | |
| 122797552 | 12279755 | 7 | 20160323 | 20160323 | 0 | |
| 122797552 | 12279755 | 8 | 20160323 | 20160323 | 0 | |
| 122797552 | 12279755 | 9 | 20160323 | 20160323 | 0 |